Scholars@Duke
Caroline Falvey

Current Appointments & Affiliations

Recent Publications

Evaluating the performance of a resampling approach for internally validating the association between a time-dependent binary indicator and time-to-event outcome.

Journal Article J Biopharm Stat · April 27, 2025 Identifying clinical or biological risk factors for disease plays a critical role in enabling earlier disease diagnosis, prognostic outcomes assessment, and may inform disease prevention or monitoring practices. One framework commonly examined is understan ... Full text Link to item Cite

Treatment Patterns, Efficacy, and Tolerability of Belantamab Mafodotin in Patients With Relapsed and/or Refractory Multiple Myeloma: A Real-World Analysis.

Journal Article Clin Lymphoma Myeloma Leuk · April 15, 2025 PURPOSE: Belantamab mafodotin is an anti-B cell maturation antigen (BCMA) immunoconjugate for patients with relapsed/refractory multiple myeloma (RRMM). Additional data on its treatment patterns, efficacy, and tolerability in real-world settings are needed ... Full text Link to item Cite

Real-world analysis of belantamab mafodotin (belamaf): Care patterns in relapsed/refractory multiple myeloma.

Journal Article Journal of Clinical Oncology · June 1, 2024 e19507 Background: Belamaf is an anti-B cell maturation antigen immunoconjugate for relapsed/refractory multiple myeloma that has shown efficacy and safety in the DREAMM clinical trials. Additional long-term real-world data on it ... Full text Cite
View All Publications

External Links

Google Scholar LinkedIn Github